Cargando…
Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report
Mesothelioma in situ (MIS) is defined as a preinvasive mesothelioma that forms a single layer of mild atypical mesothelial cells lining on the serosa surface of pleura. The atypical mesothelial cells present loss of BRCA-1 associated protein-1 (BAP-1) and/or methylthioadenosine phosphorylase as exam...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641808/ https://www.ncbi.nlm.nih.gov/pubmed/36420072 http://dx.doi.org/10.3892/ol.2022.13560 |
_version_ | 1784826164223672320 |
---|---|
author | Yabuuchi, Yuki Hiroshima, Kenzo Oshima, Hisayuki Kanazawa, Jun Hayashihara, Kenji Nakagawa, Takayuki Shimanouchi, Masaki Usui, Shingo Oh-Ishi, Shuji Saito, Takefumi Hizawa, Nobuyuki Minami, Yuko |
author_facet | Yabuuchi, Yuki Hiroshima, Kenzo Oshima, Hisayuki Kanazawa, Jun Hayashihara, Kenji Nakagawa, Takayuki Shimanouchi, Masaki Usui, Shingo Oh-Ishi, Shuji Saito, Takefumi Hizawa, Nobuyuki Minami, Yuko |
author_sort | Yabuuchi, Yuki |
collection | PubMed |
description | Mesothelioma in situ (MIS) is defined as a preinvasive mesothelioma that forms a single layer of mild atypical mesothelial cells lining on the serosa surface of pleura. The atypical mesothelial cells present loss of BRCA-1 associated protein-1 (BAP-1) and/or methylthioadenosine phosphorylase as examined by immunohistochemistry (IHC) and/or homozygous deletion of cyclin-dependent kinase inhibitor 2A/p16 as examined by fluorescence in situ hybridization. It is difficult to diagnose because of the unremarkable clinical findings except for pleural effusion. The present report describes a case in which MIS was diagnosed at the time of sampling due to the presence of clearly malignant mesothelial cells in the pleural fluid. In 2016, a 74-year-old man with a history of past exposure to asbestos was admitted to Ibaraki Higashi National Hospital (Tokai-mura, Japan) with dyspnea. Chest CT indicated only right pleural effusion. Malignant mesothelial cells were suspected in a cell block made using pleural effusion; therefore, right pleural biopsy was performed. Pathologically, there was proliferation of mesothelial cells with mild atypia that formed a single-flat layer on the pleural surface; however, there was no invasion. Furthermore, IHC revealed loss of BAP-1 in cells from the biopsied pleura and pleural effusion. MIS was suspected at the time; however, the patient arbitrarily quit his medical check-ups. After 44 months, the patient was readmitted to our hospital complaining of dyspnea. CT indicated a large right pleural mass. A specimen of the mass obtained via CT-guided needle biopsy revealed malignant mesothelioma. The patient continued to deteriorate and eventually died. This case indicated that pleural effusion could be used to demonstrate overtly malignant mesothelial cells and diagnose MIS at the time of sampling. To the best of our knowledge, this is first report of MIS with overtly malignant mesothelial cells in pleural effusion. Pleural effusion may serve an important role in MIS diagnosis. |
format | Online Article Text |
id | pubmed-9641808 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-96418082022-11-22 Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report Yabuuchi, Yuki Hiroshima, Kenzo Oshima, Hisayuki Kanazawa, Jun Hayashihara, Kenji Nakagawa, Takayuki Shimanouchi, Masaki Usui, Shingo Oh-Ishi, Shuji Saito, Takefumi Hizawa, Nobuyuki Minami, Yuko Oncol Lett Articles Mesothelioma in situ (MIS) is defined as a preinvasive mesothelioma that forms a single layer of mild atypical mesothelial cells lining on the serosa surface of pleura. The atypical mesothelial cells present loss of BRCA-1 associated protein-1 (BAP-1) and/or methylthioadenosine phosphorylase as examined by immunohistochemistry (IHC) and/or homozygous deletion of cyclin-dependent kinase inhibitor 2A/p16 as examined by fluorescence in situ hybridization. It is difficult to diagnose because of the unremarkable clinical findings except for pleural effusion. The present report describes a case in which MIS was diagnosed at the time of sampling due to the presence of clearly malignant mesothelial cells in the pleural fluid. In 2016, a 74-year-old man with a history of past exposure to asbestos was admitted to Ibaraki Higashi National Hospital (Tokai-mura, Japan) with dyspnea. Chest CT indicated only right pleural effusion. Malignant mesothelial cells were suspected in a cell block made using pleural effusion; therefore, right pleural biopsy was performed. Pathologically, there was proliferation of mesothelial cells with mild atypia that formed a single-flat layer on the pleural surface; however, there was no invasion. Furthermore, IHC revealed loss of BAP-1 in cells from the biopsied pleura and pleural effusion. MIS was suspected at the time; however, the patient arbitrarily quit his medical check-ups. After 44 months, the patient was readmitted to our hospital complaining of dyspnea. CT indicated a large right pleural mass. A specimen of the mass obtained via CT-guided needle biopsy revealed malignant mesothelioma. The patient continued to deteriorate and eventually died. This case indicated that pleural effusion could be used to demonstrate overtly malignant mesothelial cells and diagnose MIS at the time of sampling. To the best of our knowledge, this is first report of MIS with overtly malignant mesothelial cells in pleural effusion. Pleural effusion may serve an important role in MIS diagnosis. D.A. Spandidos 2022-10-25 /pmc/articles/PMC9641808/ /pubmed/36420072 http://dx.doi.org/10.3892/ol.2022.13560 Text en Copyright: © Yabuuchi et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Yabuuchi, Yuki Hiroshima, Kenzo Oshima, Hisayuki Kanazawa, Jun Hayashihara, Kenji Nakagawa, Takayuki Shimanouchi, Masaki Usui, Shingo Oh-Ishi, Shuji Saito, Takefumi Hizawa, Nobuyuki Minami, Yuko Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report |
title | Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report |
title_full | Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report |
title_fullStr | Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report |
title_full_unstemmed | Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report |
title_short | Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: A case report |
title_sort | usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma in situ: a case report |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641808/ https://www.ncbi.nlm.nih.gov/pubmed/36420072 http://dx.doi.org/10.3892/ol.2022.13560 |
work_keys_str_mv | AT yabuuchiyuki usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport AT hiroshimakenzo usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport AT oshimahisayuki usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport AT kanazawajun usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport AT hayashiharakenji usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport AT nakagawatakayuki usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport AT shimanouchimasaki usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport AT usuishingo usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport AT ohishishuji usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport AT saitotakefumi usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport AT hizawanobuyuki usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport AT minamiyuko usefulnessofmalignantpleuraleffusionforearlycytologicaldiagnosisofmesotheliomainsituacasereport |